GALNS anticorps (Middle Region)
Aperçu rapide pour GALNS anticorps (Middle Region) (ABIN952441)
Antigène
Voir toutes GALNS AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 243-271, Middle Region
-
Specificité
- This antibody recognizes Human GALNS (Center).
-
Purification
- Protein A column, followed by peptide affinity purification
-
Immunogène
- KLH conjugated synthetic peptide between 243-271 amino acids from the Central region of human GALNS
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- GALNS (Galactosamine (N-Acetyl)-6-Sulfate Sulfatase (GALNS))
-
Autre désignation
- GALNS
-
Sujet
- This gene encodes N-acetylgalactosamine-6-sulfatase which is a lysosomal exohydrolase required for the degradation of the glycosaminoglycans, keratan sulfate, and chondroitin 6-sulfate. Sequence alterations including point, missense and nonsense mutations, as well as those that affect splicing, result in a deficiency of this enzyme. Deficiencies of this enzyme lead to Morquio A syndrome, a lysosomal storage disorder. [provided by RefSeq].Synonyms: Chondroitinase, Chondroitinsulfatase, EC=3.1.6.4, GalNAc6S sulfatase, Galactose-6-sulfate sulfatase, N-acetylgalactosamine-6-sulfatase, N-acetylgalactosamine-6-sulfate sulfatase
-
Poids moléculaire
- 58026 Da
-
ID gène
- 2588
-
NCBI Accession
- NP_000503
-
Pathways
- Glycosaminoglycan Metabolic Process
Antigène
-